Cell Therapy Company and Chinese Firm Sign Marketing Deal
July 15, 2018 at 04:00 AM EDT
Source: Streetwise Reports 07/15/2018 This biotech, in Phase 1 development of regenerative technologies addressing skin and orthopedic indications, has finalized a commercialization deal with YOFOTO. On June 11, RepliCel Life Sciences Inc. (RP:TSX.V; REPCF:OTCQB) announced [...]
